skip links

Media Inquiries

Beth Calitri

Corporate Communications, Media Relations

978.417.2031

[email protected]
Sort by Year
February 11, 2013

Ironwood Pharmaceuticals Promotes Dr. Mark Currie to Senior Vice President, Chief Scientific Officer, and President of R&D

January 15, 2013

Ironwood Pharmaceuticals Provides Fourth Quarter 2012 Investor Update

January 10, 2013

Ironwood Pharmaceuticals to Host Fourth Quarter 2012 Investor Update Call

January 4, 2013

Ironwood Completes $175 Million Debt Offering

January 2, 2013

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

December 17, 2012

Ironwood and Forest Announce U.S. Availability of LINZESS™ (Linaclotide)

December 6, 2012

Protagonist and Ironwood Expand Peptide Drug Discovery Collaboration

November 28, 2012

Constella® (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults

November 9, 2012

Ironwood Pharmaceuticals to Present at the Credit Suisse 2012 Healthcare Conference

November 1, 2012

Ironwood Pharmaceuticals to Host Webinar on Accounting Treatment for LINZESS™ (Linaclotide)

October 23, 2012

Ironwood and AstraZeneca Announce Linaclotide Collaboration for China

October 16, 2012

Ironwood Pharmaceuticals Provides Third Quarter 2012 Investor Update

October 9, 2012

Ironwood Pharmaceuticals to Host Third Quarter 2012 Investor Update Call

September 21, 2012

Linaclotide Receives Positive CHMP Opinion for the Treatment of IBS-C

September 12, 2012

Ironwood Pharmaceuticals to Present at the UBS Global Life Sciences Conference